Show simple item record

dc.contributor.authorHervella ., Pablo
dc.contributor.authorRodríguez Yáñez, Manuel 
dc.contributor.authorPumar Cebreiro, José Manuel 
dc.contributor.authorÁvila Gómez, Paulo
dc.contributor.authorDa Silva Candal, Andrés Alexander
dc.contributor.authorLópez Loureiro, Ignacio
dc.contributor.authorRodríguez Maqueda, Elena
dc.contributor.authorCorrea Paz, Clara
dc.contributor.authorCastillo Sánchez, José 
dc.contributor.authorSobrino Moreiras, Tomas 
dc.contributor.authorCampos Pérez, Francisco 
dc.contributor.authorIglesias Rey, Ramón
dc.date.accessioned2022-04-26T07:43:08Z
dc.date.available2022-04-26T07:43:08Z
dc.date.issued2020
dc.identifier.issn0028-3878
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/32221027es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16521
dc.description.abstractOBJECTIVE: To investigate the effect on perihematomal hypodensity and outcome of a decrease in body temperature in the first 24 hours in patients with intracerebral hemorrhage (ICH). METHODS: In this retrospective study on a prospectively registered database, among the 1,100 patients, 795 met all the inclusion criteria. Temperature variations in the first 24 hours and perihematomal hypodensity (PHHD) were recorded. Patients >/=37.5 degrees C were treated with antihyperthermic drugs for at least 48 hours. The main objective was to determine the association among temperature variation, PHHD, and outcome at 3 months. RESULTS: The decrease in temperature in the first 24 hours increased the possibility of good outcome 11-fold. Temperature decrease, lower PHHD volume, and a good outcome were observed in 31.8% of the patients who received antihyperthermic treatment. CONCLUSION: The administration of early antihyperthermic treatment in patients with spontaneous ICH with a basal axillary temperature >/=37.5 degrees C resulted in good outcome in a third of the treated patients.en
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshBody Temperature*
dc.subject.meshFever*
dc.subject.meshMiddle Aged*
dc.subject.meshHumans*
dc.subject.meshCerebral Hemorrhage*
dc.subject.meshHematoma*
dc.subject.meshDipyrone*
dc.subject.meshAcetaminophen*
dc.subject.meshRetrospective Studies*
dc.subject.meshAged*
dc.subject.meshPrognosis*
dc.subject.meshAntipyretics*
dc.titleAntihyperthermic treatment decreases perihematomal hypodensityen
dc.typeJournal Articlees
dc.authorsophosHervella, P.;Rodríguez-Yáñez, M.;Pumar, J. M.;Ávila-Gómez, P.;da Silva-Candal, A.;López-Loureiro, I.;Rodríguez-Maqueda, E.;Correa-Paz, C.;Castillo, J.;Sobrino, T.;Campos, F.;Iglesias-Rey, R.
dc.identifier.doi10.1212/WNL.0000000000009288
dc.identifier.pmid32221027
dc.identifier.sophos39134
dc.issue.number16es
dc.journal.titleNEUROLOGYes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Neuroloxíaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Radiodiagnósticoes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)es
dc.page.initiale1738es
dc.page.finale1748es
dc.rights.accessRightsopenAccess
dc.subject.decspronóstico*
dc.subject.decsdipirona*
dc.subject.decsanciano*
dc.subject.decstemperatura corporal*
dc.subject.decsantipiréticos*
dc.subject.decshemorragia cerebral*
dc.subject.decsestudios retrospectivos*
dc.subject.decshematoma*
dc.subject.decsmediana edad*
dc.subject.decshumanos*
dc.subject.decsfiebre*
dc.subject.decsacetaminofén*
dc.subject.keywordCHUSes
dc.subject.keywordIDISes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number94es


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International